212 related articles for article (PubMed ID: 12956723)
1. Regulation of DARPP-32 Thr75 phosphorylation by neurotensin in neostriatal neurons: involvement of glutamate signalling.
Matsuyama S; Fukui R; Higashi H; Nishi A
Eur J Neurosci; 2003 Sep; 18(5):1247-53. PubMed ID: 12956723
[TBL] [Abstract][Full Text] [Related]
2. Neurotensin regulates DARPP-32 thr34 phosphorylation in neostriatal neurons by activation of dopamine D1-type receptors.
Matsuyama S; Higashi H; Maeda H; Greengard P; Nishi A
J Neurochem; 2002 Apr; 81(2):325-34. PubMed ID: 12064480
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of dopamine D1 and D2 signaling by nicotine in neostriatal neurons.
Hamada M; Higashi H; Nairn AC; Greengard P; Nishi A
J Neurochem; 2004 Sep; 90(5):1094-103. PubMed ID: 15312165
[TBL] [Abstract][Full Text] [Related]
4. Effect of methylphenidate on dopamine/DARPP signalling in adult, but not young, mice.
Fukui R; Svenningsson P; Matsuishi T; Higashi H; Nairn AC; Greengard P; Nishi A
J Neurochem; 2003 Dec; 87(6):1391-401. PubMed ID: 14713295
[TBL] [Abstract][Full Text] [Related]
5. Regulation of DARPP-32 dephosphorylation at PKA- and Cdk5-sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase-2A.
Nishi A; Bibb JA; Matsuyama S; Hamada M; Higashi H; Nairn AC; Greengard P
J Neurochem; 2002 May; 81(4):832-41. PubMed ID: 12065642
[TBL] [Abstract][Full Text] [Related]
6. Nicotine regulates DARPP-32 (dopamine- and cAMP-regulated phosphoprotein of 32 kDa) phosphorylation at multiple sites in neostriatal neurons.
Hamada M; Hendrick JP; Ryan GR; Kuroiwa M; Higashi H; Tanaka M; Nairn AC; Greengard P; Nishi A
J Pharmacol Exp Ther; 2005 Nov; 315(2):872-8. PubMed ID: 16040813
[TBL] [Abstract][Full Text] [Related]
7. Regulation of spinophilin Ser94 phosphorylation in neostriatal neurons involves both DARPP-32-dependent and independent pathways.
Uematsu K; Futter M; Hsieh-Wilson LC; Higashi H; Maeda H; Nairn AC; Greengard P; Nishi A
J Neurochem; 2005 Dec; 95(6):1642-52. PubMed ID: 16300646
[TBL] [Abstract][Full Text] [Related]
8. Role of adenosine A1 receptors in the modulation of dopamine D1 and adenosine A2A receptor signaling in the neostriatum.
Yabuuchi K; Kuroiwa M; Shuto T; Sotogaku N; Snyder GL; Higashi H; Tanaka M; Greengard P; Nishi A
Neuroscience; 2006 Aug; 141(1):19-25. PubMed ID: 16750892
[TBL] [Abstract][Full Text] [Related]
9. Muscarinic acetylcholine M
Liu L; Huang Y; Huang Q; Zhao Z; Yu J; Wang L
Neuropharmacology; 2017 May; 117():376-386. PubMed ID: 28257887
[TBL] [Abstract][Full Text] [Related]
10. Role of calcineurin and protein phosphatase-2A in the regulation of DARPP-32 dephosphorylation in neostriatal neurons.
Nishi A; Snyder GL; Nairn AC; Greengard P
J Neurochem; 1999 May; 72(5):2015-21. PubMed ID: 10217279
[TBL] [Abstract][Full Text] [Related]
11. Regulation of DARPP-32 phosphorylation by three distinct dopamine D1-like receptor signaling pathways in the neostriatum.
Kuroiwa M; Bateup HS; Shuto T; Higashi H; Tanaka M; Nishi A
J Neurochem; 2008 Nov; 107(4):1014-26. PubMed ID: 18823371
[TBL] [Abstract][Full Text] [Related]
12. Glutamate regulation of DARPP-32 phosphorylation in neostriatal neurons involves activation of multiple signaling cascades.
Nishi A; Watanabe Y; Higashi H; Tanaka M; Nairn AC; Greengard P
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1199-204. PubMed ID: 15657149
[TBL] [Abstract][Full Text] [Related]
13. The mesolimbic dopaminergic response to novel palatable food consumption increases dopamine-D1 receptor-mediated signalling with complex modifications of the DARPP-32 phosphorylation pattern.
Rauggi R; Scheggi S; Cassanelli A; De Montis MG; Tagliamonte A; Gambarana C
J Neurochem; 2005 Feb; 92(4):867-77. PubMed ID: 15686489
[TBL] [Abstract][Full Text] [Related]
14. Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons.
Hara M; Fukui R; Hieda E; Kuroiwa M; Bateup HS; Kano T; Greengard P; Nishi A
J Neurochem; 2010 May; 113(4):1046-59. PubMed ID: 20236221
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic receptors acting at pre- and post-synaptic sites differentially regulate dopamine/DARPP-32 signaling in striatonigral and striatopallidal neurons.
Kuroiwa M; Hamada M; Hieda E; Shuto T; Sotogaku N; Flajolet M; Snyder GL; Hendrick JP; Fienberg A; Nishi A
Neuropharmacology; 2012 Dec; 63(7):1248-57. PubMed ID: 22971543
[TBL] [Abstract][Full Text] [Related]
16. Behavioral expression of cocaine sensitization in rats is accompanied by a distinct pattern of modifications in the PKA/DARPP-32 signaling pathway.
Scheggi S; Raone A; De Montis MG; Tagliamonte A; Gambarana C
J Neurochem; 2007 Nov; 103(3):1168-83. PubMed ID: 17680995
[TBL] [Abstract][Full Text] [Related]
17. D(1) dopamine receptor activation reduces GABA(A) receptor currents in neostriatal neurons through a PKA/DARPP-32/PP1 signaling cascade.
Flores-Hernandez J; Hernandez S; Snyder GL; Yan Z; Fienberg AA; Moss SJ; Greengard P; Surmeier DJ
J Neurophysiol; 2000 May; 83(5):2996-3004. PubMed ID: 10805695
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D1 receptor-dependent modifications in the dopamine and cAMP-regulated phosphoprotein of Mr 32 kDa phosphorylation pattern in striatal areas of morphine-sensitized rats.
Scheggi S; Crociani A; De Montis MG; Tagliamonte A; Gambarana C
Neuroscience; 2009 Oct; 163(2):627-39. PubMed ID: 19559764
[TBL] [Abstract][Full Text] [Related]
19. Regulation of AMPA receptor dephosphorylation by glutamate receptor agonists.
Snyder GL; Galdi S; Fienberg AA; Allen P; Nairn AC; Greengard P
Neuropharmacology; 2003 Nov; 45(6):703-13. PubMed ID: 14529709
[TBL] [Abstract][Full Text] [Related]
20. Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling.
Nishi A; Liu F; Matsuyama S; Hamada M; Higashi H; Nairn AC; Greengard P
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1322-7. PubMed ID: 12538871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
